CL2018000033A1 - Composición para destapar una nariz tapada que tiene actividad antiviral. - Google Patents
Composición para destapar una nariz tapada que tiene actividad antiviral.Info
- Publication number
- CL2018000033A1 CL2018000033A1 CL2018000033A CL2018000033A CL2018000033A1 CL 2018000033 A1 CL2018000033 A1 CL 2018000033A1 CL 2018000033 A CL2018000033 A CL 2018000033A CL 2018000033 A CL2018000033 A CL 2018000033A CL 2018000033 A1 CL2018000033 A1 CL 2018000033A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- uncover
- carragenine
- ionic
- antiviral activity
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000002727 hyperosmolar Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15176670 | 2015-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2018000033A1 true CL2018000033A1 (es) | 2018-08-10 |
Family
ID=53717900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018000033A CL2018000033A1 (es) | 2015-07-14 | 2018-01-05 | Composición para destapar una nariz tapada que tiene actividad antiviral. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10660914B2 (enExample) |
| EP (1) | EP3370692B1 (enExample) |
| JP (1) | JP6774435B2 (enExample) |
| KR (1) | KR102628781B1 (enExample) |
| CN (1) | CN107847430B (enExample) |
| AU (1) | AU2016293004B2 (enExample) |
| BR (1) | BR112018000592B1 (enExample) |
| CA (1) | CA2992352C (enExample) |
| CL (1) | CL2018000033A1 (enExample) |
| DK (1) | DK3370692T3 (enExample) |
| EA (1) | EA037085B1 (enExample) |
| ES (1) | ES2949139T3 (enExample) |
| FI (1) | FI3370692T3 (enExample) |
| HU (1) | HUE062108T2 (enExample) |
| IL (1) | IL256883B (enExample) |
| LT (1) | LT3370692T (enExample) |
| MA (1) | MA43155A (enExample) |
| MX (1) | MX372625B (enExample) |
| MY (1) | MY194870A (enExample) |
| NZ (1) | NZ738597A (enExample) |
| PH (1) | PH12018500044B1 (enExample) |
| PL (1) | PL3370692T3 (enExample) |
| PT (1) | PT3370692T (enExample) |
| SA (1) | SA518390689B1 (enExample) |
| WO (1) | WO2017009351A1 (enExample) |
| ZA (1) | ZA201708595B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11357791B2 (en) * | 2016-02-17 | 2022-06-14 | Ent Technologies Pty Ltd | Compositions and methods for the treatment of sinus disease and disorders |
| GB2567285A (en) * | 2017-08-07 | 2019-04-10 | Suprapharm Cc | Preparation for nasal-nasopharyngeal treatment |
| WO2021262141A1 (en) * | 2020-06-22 | 2021-12-30 | Mario Elmen Tremblay | Personal lubricants comprising lambda-carrageenan |
| JP2023517239A (ja) | 2020-03-12 | 2023-04-24 | デイヴィッド カリス－ヒル、シドニー | コロナウイルス感染症および関連するサイトカイン毒性の治療 |
| CN111437270A (zh) * | 2020-04-24 | 2020-07-24 | 瑞希(重庆)生物科技有限公司 | 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法 |
| US11013687B1 (en) | 2020-06-08 | 2021-05-25 | Amcyte Pharma, Inc. | Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2 |
| WO2021253643A1 (zh) * | 2020-06-18 | 2021-12-23 | 大连工业大学 | 硫酸化多糖在抗新型冠状病毒中的应用 |
| CN111686125A (zh) * | 2020-06-18 | 2020-09-22 | 大连工业大学 | 卡拉胶在抗新型冠状病毒中的应用 |
| EP3939597A1 (en) * | 2020-07-16 | 2022-01-19 | Marinomed Biotech AG | Antiviral pharmaceutical composition comprising a carrageenan component |
| EP4192424A1 (fr) | 2020-08-04 | 2023-06-14 | Cosmosoft | Hydrogel comprenant du glycerol et un carbomere pour le traitement par voie nasale des symptomes respiratoires de la maladie covid-19 |
| FR3113237B1 (fr) | 2020-08-04 | 2023-06-09 | Biopass | Produit pour le traitement de maladies virales par voie nasale |
| DE202020004186U1 (de) * | 2020-10-05 | 2020-10-21 | Christian Fleischhammel | Antiinfektive Arzneiform zur Herstellung einer Nasenspülung gegen COVID-19 |
| EP3991561A1 (en) * | 2020-10-28 | 2022-05-04 | Vepidan ApS | Antimicrobial disinfectant gel |
| GB202109888D0 (en) | 2021-07-08 | 2021-08-25 | Pollinner Ltd | Nasal spray |
| KR102720037B1 (ko) * | 2021-12-21 | 2024-10-22 | (주)메디코어 | 비강 세정제 조성물 및 그 제조방법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2653021A1 (fr) * | 1989-10-17 | 1991-04-19 | Merck Sharp & Dohme | Composition ophtalmique aqueuse liquide a transition de phase liquide-gel. |
| US6080783A (en) * | 1998-09-01 | 2000-06-27 | Gum Tech International, Inc. | Method and composition for delivering zinc to the nasal membrane |
| PL2486942T3 (pl) * | 2004-11-24 | 2019-05-31 | Meda Pharmaceuticals Inc | Kompozycje zawierające azelastynę oraz sposoby ich stosowania |
| US20080241271A1 (en) * | 2006-11-08 | 2008-10-02 | Roman Stephen B | Foaming anti-adhesion composition |
| SI2101792T1 (sl) | 2006-12-05 | 2010-08-31 | Marinomed Biotechnologie Gmbh | Uporaba karagenana za zdravljenje rinovirusnih infekcij |
| JP4941977B2 (ja) * | 2007-04-11 | 2012-05-30 | 大蔵製薬株式会社 | ベンズイソキサゾール誘導体の経口ゼリー状医薬組成物 |
| SI2178533T1 (sl) | 2007-08-24 | 2013-07-31 | Marinomed Biotechnologie Gmbh | Antivirusni sestavek, ki obsega sulfatiran polisaharid: iota-karagenan |
| WO2009060915A1 (ja) * | 2007-11-06 | 2009-05-14 | San-Ei Gen F.F.I., Inc. | 唾液分泌促進剤 |
| FR2926218B1 (fr) * | 2008-01-10 | 2010-08-13 | Galderma Res & Dev | Composition comprenant un retinoide et du peroxyde de benzoyle disperse. |
| WO2013049538A1 (en) * | 2011-09-30 | 2013-04-04 | Mcneil-Ppc, Inc. | Allergen nasal compositions |
-
2016
- 2016-07-12 AU AU2016293004A patent/AU2016293004B2/en active Active
- 2016-07-12 PT PT167384197T patent/PT3370692T/pt unknown
- 2016-07-12 FI FIEP16738419.7T patent/FI3370692T3/fi active
- 2016-07-12 US US15/767,273 patent/US10660914B2/en active Active
- 2016-07-12 KR KR1020187004269A patent/KR102628781B1/ko active Active
- 2016-07-12 BR BR112018000592-4A patent/BR112018000592B1/pt active IP Right Grant
- 2016-07-12 CA CA2992352A patent/CA2992352C/en active Active
- 2016-07-12 NZ NZ738597A patent/NZ738597A/en unknown
- 2016-07-12 HU HUE16738419A patent/HUE062108T2/hu unknown
- 2016-07-12 ES ES16738419T patent/ES2949139T3/es active Active
- 2016-07-12 EP EP16738419.7A patent/EP3370692B1/en active Active
- 2016-07-12 EA EA201890196A patent/EA037085B1/ru unknown
- 2016-07-12 JP JP2017565990A patent/JP6774435B2/ja active Active
- 2016-07-12 LT LTEPPCT/EP2016/066565T patent/LT3370692T/lt unknown
- 2016-07-12 MA MA043155A patent/MA43155A/fr unknown
- 2016-07-12 DK DK16738419.7T patent/DK3370692T3/da active
- 2016-07-12 WO PCT/EP2016/066565 patent/WO2017009351A1/en not_active Ceased
- 2016-07-12 CN CN201680039448.1A patent/CN107847430B/zh active Active
- 2016-07-12 MX MX2018000285A patent/MX372625B/es active IP Right Grant
- 2016-07-12 PL PL16738419.7T patent/PL3370692T3/pl unknown
- 2016-07-12 MY MYPI2017704939A patent/MY194870A/en unknown
- 2016-07-12 PH PH1/2018/500044A patent/PH12018500044B1/en unknown
-
2017
- 2017-12-18 ZA ZA2017/08595A patent/ZA201708595B/en unknown
-
2018
- 2018-01-03 SA SA518390689A patent/SA518390689B1/ar unknown
- 2018-01-05 CL CL2018000033A patent/CL2018000033A1/es unknown
- 2018-01-11 IL IL256883A patent/IL256883B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018000285A (es) | Composicion para desobstruir la nariz congestionada que tiene actividad antiviral. | |
| NI201400842A (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas. | |
| CL2020000739A1 (es) | Agente prolongado de control de ectoparasito para animales. | |
| JOP20170135A1 (ar) | مركبات ديازاسبيروألكيل مثيل-إندول | |
| BR122021018243A8 (pt) | Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável | |
| AR104212A1 (es) | Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina, métodos y usos de las mismas | |
| MX387788B (es) | Uso de agentes activos durante tratamientos quimicos. | |
| AR103803A1 (es) | Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas | |
| BR112013018920A2 (pt) | composições de nanopartículas, formulações destas e seus usos | |
| BR112019004496A2 (pt) | estabilizantes de mastócitos para tratamento de hipercitocinemia e infecção viral | |
| TR201904455T4 (tr) | Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları. | |
| MX2020006309A (es) | Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis. | |
| CO2020002624A2 (es) | Formulación de uso tópico para el control y la prevención de parásitos en animales | |
| WO2016044839A3 (en) | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses | |
| WO2015081904A3 (en) | Polyurethaneurea solutions for compositions with active ingredients or fragrances | |
| MX2018011539A (es) | Tratamiento de dolencias y enfermedades cutaneas asociadas a biopeliculas microbianas. | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| BR112015028334A2 (pt) | agente e método para o tratamento de herpes | |
| MX2017011040A (es) | Agente para el tratamiento de infeccion respiratoria. | |
| EA201890789A1 (ru) | Содержащая цинеол композиция для лечения заболеваний носа | |
| WO2014137231A3 (en) | Totarol extract formulations and uses thereof | |
| AR100850A1 (es) | Composición farmacéutica que comprende desmopresina y un agente estabilizador | |
| PE20242218A1 (es) | Composicion topica que comprende un extracto de ophiopogon para uso en el tratamiento de los parpados o el contorno del ojo |